FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech's biosimilar to Humira® ...

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech's biosimilar to Humira® Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech's two Reykjavik drug substance suites